Pharmaceutical

AbbVie achieves win for migraine prevention drug Aquipta in Europe

The decision brings the first daily oral migraine prophylactic to Europe, with plans to rollout the treatment as soon as possible.

Aug 18, 2023 - 20:00
AbbVie achieves win for migraine prevention drug Aquipta in Europe
The decision brings the first daily oral migraine prophylactic to Europe, with plans to rollout the treatment as soon as possible.
Read the original article

Tags:

Previous Article

STAT+: With an age cutoff for a new gene therapy, families and doctors scramble ...

Next Article

Boehringer Ingelheim advances weight loss drug to Phase III trials

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: CRISPR’s pioneers reflect on the first gene-editing treatment

STAT+: CRISPR’s pioneers reflect on the first gene-edit...

Nov 19, 2023

FDA grants fast track status to Edgewise’s Duchenne treatment

FDA grants fast track status to Edgewise’s Duchenne tre...

Feb 14, 2024

Genetically altered pig heart transplanted into a human for the second time

Genetically altered pig heart transplanted into a human...

Sep 22, 2023